Hepatitis C virus seroprevalence in multi-transfused patients in Colombia

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 2, 2005, Pages

  Beltrân, Mauricio ^a   Navas, Maria Cristina ^b   De La Hoz, Fernando ^a,h   Mercedes Muñoz, Maria ^c   Jaramillo, Sergio ^d   Estrada, Cecilia ^e   Del Pilar Cortés, Lucia ^f   Arbelâez, María Patricia ^b   Donado, Jorge ^b,d   Barco, Gloria ^e   Luna, Martha ^e   Uribe, Gustavo Adolfo ^c   De Maldonado, Amalia ^b   Restrepo, Juan Carlos ^b   Correa, Gonzalo ^b   Borda, Paula ^a   Rey, Gloria ^a   De Neira, Marlen ^a   Estrada, Angela ^d   Yepes, Sandra ^d   Beltrân, Oscar ^c   Pacheco, Javier ^f   Villegas, Iván ^g   Boshell, Jorge ^a,i   more..

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c Instituto de Seguros Sociales Bogota   (Colombia)

^d HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^e Instituto de Los Seguros Sociales   (Colombia)

^f Instituto Nacional de Cancerología   (Colombia)

^g Renal Unit   (Colombia)

^h Programa Ciencia Y Tecnología de la Salud   (Colombia)

ⁱ Secretaria de Salud del Meta   (Colombia)

Author keywords

Colombia; HCV; Multi transfused patients; Prevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLEEDING; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; COLOMBIA; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; SICKLE CELL; THALASSEMIA;

ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; COLOMBIA; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEMOPHILIA A; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALS; HUMANS; MALE; RENAL DIALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 32044447707     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80032-0     Document Type: Article

References (23)

1. Alberti A., and Benvegnu M.L. Management of hepatitis C J Hepatol 38 2003 S104 S118
2. Barrera J.M., Bruguera M., Ercilla M.G., Sanchez-Tapias J.M., Gil M.P., and Costa J. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers Ann Intern Med. 115 8 1991 596 600
3. Beltrán M., Ayala M., and Ching R. Situación actual del tamizaje en bancos de sangre Biomédica 16 2 1997 51 52
4. Beltrán M., Raad J., Ayala M., and Ching R. Tamizaje de enfermedades infecciosas en bancos de sangre, Colombia, 1995 Biomédica 17 2 1997 137 142
5. CDC Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV related chronic disease MMWR 47 RR19 1998 1 39
6. Consenso Colombiano de Hepatitis C Repertorio de medicina y cirugia 11 2002 8 38
7. Cortes A., Beltrán M., Olaya B., and Hernández M. Riesgo de enfermedades infecciosas transmitidas por transfusión en et Valle del Cauca Colombia Médica 30 1999 13 18
8. Cortes A., Beltran M., Olaya B., and Hernandez M. Epidemiologia de la coleccion, proceso y use de la sangre y componentes sanguineos en et Valle del Cauca. Colombia Colombia Médica 30 1 1999 29 35
9. De la Hoz F.P. Hepatitis C epidemiology in Latin America and Colombia Biomédica 20 1 2000 66 72
10. Donahue J.G., Munoz A., Ness P.M., Brown D.E. Jr, Yawn D.H., and McAllister H.A. Jr The declining risk of post-transfusion hepatitis C virus infection N Engl J Med. 327 6 1992 369 373
11. Echavarria E. Estudios de anticuerpos contra et virus de la Hepatitis C en donantes de sangre y grupos alto riesgo Acta Médica Colombiana 17 1992 11 15
12. Fink F.M., Hocker-Schulz S., Mor W., Puchhammer-Stock E., Hofmann H., and Zoubek A. Association of hepatitis C virus infection with chronic liver in pediatric cancer patients Eur J Pediatr 152 1993 490 492
13. Kane A., Lloyd J., Zaffran M., Simonsen L., and Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regionalestimates Bull WHO 77 10 1999 801 807
14. Lai M.E., De Virgilis S., Argiolu F., Farci P., Mazzoleni A.P., and Lisci V. Evaluation of antibodies to hepatitis C virus in a longterm prospective study of posttransfusion hepatitis among thalassemic children: comparisonbetween first- and second-generation assay J Pediatr Gastroenterol Nutr. 16 4 1993 458 464
15. Luby S.P., Qamruddin K., Shah A.A., Omair A., Pahsa O., and Khan A.J. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan Epidemiol Infect 119 3 1997 349 356
16. Ministerio de Salud Instituto Nacional de Salud Boletin epidemiológico SIVIGILA 42 2002 2 3
17. Penin F., Dubuisson J., Rey F.A., Moradpour D., and Pawlotsky J.M. Structural biology of hepatitis C virus Hepatology 39 1 2004 5 19
18. Schmunis G.A., Zicker F., Pinheiro F., and Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America Emerg Infect Dis. 4 1 1998 5 11
19. Schmunis G.A., Zicker F., Cruz J.R., and Cuchi P. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997 Am J Trop Med Hyg. 65 6 2001 924 930
20. Simonsen L., Kane A., Lloyd J., Zaffran M., and Kane M. Unsafe injections in the developing world and transmission of bloodbome pathogens: a review Bull WHO 77 10 1999 789 800
21. Velandia M., Fridkin S.K., and Cardenas V. Transmission of HIV in dialysis center Lancet 345 1995 1417 1422
22. WHO (World Health Organization) Hepatitis C-Global prevalence (update) Wkly Epidemiol Rec 75 2000 18 19
23. WHO (World Health Organization) Global distribution of hepatitis A, B and C, 2001 Wkly Epidemiol Rec 77 6 2002 45 47